Thought Leadership + Events
Abbott sees new a physician-patient dynamic ushered in by the “convergence of health and technology to empower human lives. Healthtech is at an inflection point. We’re creating a future that will bring care that is more personal and precise, and will take human capabilities to entirely new levels. A future where people can manage their own health—decentralize and democratize healthcare. With the right tools we can give everyone the best chance to live their best lives.”
Abbott sees the delivery system as a differentiator for its TAVR, and this is a great strategic choice on the part of Abbott. They've made the decision to improve all aspects of their Portico TAVR device, not just the valve itself. TAVR is a bare knuckles fighting market. But, if you make the device easier to use and place, it can grab a critical share of market for your product. Santosh Prabhu—divisional VP, product development of Abbott Structural Heart outlined 5 ways they improved the delivery system for the Portico device…
What price premium can be charged for an upgraded legacy product in a commodity space?
Medtech price sensitivity analysis - hospital administrators and CFOs
M&A due diligence analysis: pricing for a new disruptive product
Justifying an increased price is always a challenge in the medical device space. But, if the next generation feature set warrants a price increase, we can help your marketing teams articulate and quantify your product’s value.
